Your account is not claimed yet. You can sign up with ORCID to claim your account.

Stephen A Cochrane

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

RSC medicinal chemistry

Chemical communications (Cambridge, England)

Journal of medicinal chemistry

ACS infectious diseases

Queen's University Belfast

University of Alberta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Queen's University Belfast Mar 4o 2017

United Kingdom

Lecturer in Organic Chemistry :: Chemistry and Chemical Engineering

Education History

University of Alberta Sep 1o 2010 - Nov 30o 2015

Canada

PHD :: Chemistry

Publications

Ned P Buijs, Eilidh J Matheson, Stephen A Cochrane, Nathaniel I Martin
Targeting membrane-bound bacterial cell wall precursors: a tried and true antibiotic strategy in nature and the clinic. Chemical communications (Cambridge, England) (2023)
Ross D Ballantine, Karol Al Ayed, Samantha J Bann, Michael Hoekstra, Nathaniel I Martin, Stephen A Cochrane
Linearization of the Brevicidine and Laterocidine Lipopeptides Yields Analogues That Retain Full Antibacterial Activity. Journal of medicinal chemistry (2023)
Karol Al Ayed, Ross D Ballantine, Michael Hoekstra, Samantha J Bann, Charlotte M J Wesseling, Alexander T Bakker, Zheng Zhong, Yong-Xin Li, Nora C Brüchle, Mario van der Stelt, Stephen A Cochrane, Nathaniel I Martin
Synthetic studies with the brevicidine and laterocidine lipopeptide antibiotics including analogues with enhanced properties and in vivo efficacy. Chemical science 13 (12) (2022)
Ross D Ballantine, Karol Al Ayed, Samantha J Bann, Michael Hoekstra, Nathaniel I Martin, Stephen A Cochrane
Synthesis and structure-activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine. RSC medicinal chemistry 13 (12) (2022)
Ross D Ballantine, Karol Al Ayed, Samantha J Bann, Michael Hoekstra, Nathaniel I Martin, Stephen A Cochrane
Synthesis and structure-activity relationship studies of N-terminal analogues of the lipopeptide antibiotics brevicidine and laterocidine. RSC medicinal chemistry 13 (12) (2022)
Ioli Kotsogianni, Thomas M Wood, Francesca M Alexander, Stephen A Cochrane, Nathaniel I Martin
Binding Studies Reveal Phospholipid Specificity and Its Role in the Calcium-Dependent Mechanism of Action of Daptomycin. ACS infectious diseases 7 (9) (2021)
Samantha J Bann, Ross D Ballantine, Stephen A Cochrane
The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria. RSC medicinal chemistry 12 (4) (2021)
Samantha J Bann, Ross D Ballantine, Conor E McCallion, Pei-Yuan Qian, Yong-Xin Li, Stephen A Cochrane
A Chemical-Intervention Strategy To Circumvent Peptide Hydrolysis by d-Stereoselective Peptidases. Journal of medicinal chemistry 62 (22) (2019)
Ross D Ballantine, Conor E McCallion, Elie Nassour, Sima Tokajian, Stephen A Cochrane
Tridecaptin-inspired antimicrobial peptides with activity against multidrug-resistant Gram-negative bacteria. MedChemComm 10 (3) (2019)
Ross D Ballantine, Yong-Xin Li, Pei-Yuan Qian, Stephen A Cochrane
Rational design of new cyclic analogues of the antimicrobial lipopeptide tridecaptin A1. Chemical communications (Cambridge, England) 54 (75) (2018)
Alireza Bakhtiary, Stephen A Cochrane, Pascal Mercier, Ryan T McKay, Mark Miskolzie, Clarissa S Sit, John C Vederas
Insights into the Mechanism of Action of the Two-Peptide Lantibiotic Lacticin 3147. Journal of the American Chemical Society 139 (49) (2017)

Stephen A Cochrane.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Stephen A Cochrane